Latest Equity Capital News

Kula Gold Limited has reported impressive high-grade gold drilling results at its Mt Palmer Gold Mine, completing an 80% JV earn-in, while progressing exploration at Kirup and securing a niobium project approval in Malawi. The company faces a tight cash position but is actively managing funding.

Peninsula Energy has locked in a $15 million debt facility from Davidson Kempner to advance commissioning at its Lance uranium project and support an upcoming equity raise. The funding aims to sustain momentum towards production resumption and ASX relisting.

Xstate Resources has launched a $2-3 million capital raising with a priority offer to existing shareholders, coinciding with a shareholder meeting to approve a key acquisition.

Washington H. Soul Pattinson and Brickworks have announced a conditional placement of 14 million Topco shares and a concurrent repurchase of up to $450 million in convertible notes, setting the stage for their upcoming merger.

Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.

North Stawell Minerals Ltd (ASX, NSM) is advancing its gold exploration ambitions with a $3.6 million equity raising aimed at funding key projects near the prolific Stawell Gold Mine in Victoria. The capital injection will support drilling and geological modelling to unlock new gold discoveries under a thin sediment cover.

Pacific Edge Limited reported a resilient FY25 performance despite losing Medicare coverage for its Cxbladder tests in the US, announcing a $20 million equity raise to support commercialization and growth.

Rapid Lithium Limited has agreed to acquire two high-grade silver projects in New South Wales, adding nearly 35 million silver equivalent ounces to its portfolio. The deal, valued at A$6.5 million, signals a strategic diversification into critical minerals amid a robust silver market.

Bell Financial Group delivered strong financial results for 2024, driven by growth in technology and product services, but early 2025 shows challenges from market volatility impacting core broking revenues.

Noxopharm Limited has raised nearly $2.5 million by selling its entire stake in Nyrada Inc, providing non-dilutive capital to advance its HERACLES clinical trial and expand its research pipeline.

Highfield Resources has obtained a standby loan facility from EMR Capital to support its operations and strategic transaction progress, including advancing its flagship Muga Project. The company also extended the maturity of its convertible loan notes, underscoring ongoing investor confidence during a pivotal phase.

Macquarie Group reported a 5% increase in full-year net profit to A$3.7 billion for FY25, driven by strong second-half growth and robust asset management performance. The company declared a final dividend of A$3.90 per share and extended its share buyback program.